Suppression of ouabain induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents

P. R. Foster, R. M. King, A. DeB Nicoll, D. P. Zipes

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Three groups of dogs were given ouabain (mean 60 μg/kg) until an accelerated ventricular escape (AVE) and repetitive ventricular response (RVR) followed cessation of pacing. In a group of six control dogs, the AVE and RVR were found to occur at stable escape intervals for periods of at least three hours. A second group of dogs received various antiarrhythmic agents in an attempt to suppress the AVE and RVR. Quinidine, diphenylhydantoin, lidocaine, procainamide, and propranolol, were successful in only 0 to 33% of trials. Potassium canrenoate, 12 mg/kg was unsuccessful in three dogs. Verapamil, by bolus, suppressed RVR in 41% and AVE in 21% of trials. KCl, infused until AVE and RVR were suppressed, was successful when the mean serum potassium rose from 3.8 mEq/L to 7.2 mEq/L. Aprindine, 2.86 mg/kg, suppressed AVE and RVR in 14 of 14 dogs. In the third group of dogs, verapamil was infused continuously and suppressed RVR and AVE at a mean cumulative dose of 2.93 mg/kg. Calcium chloride reversed aprindine and verapamil induced suppression of RVR and AVE. This study demonstrates that RVR and AVE resist suppression by available antiarrhythmic agents in clinically used doses. Only aprindine was 100% successful at doses used in man. The ionic pathogenesis of RVR and AVE is unknown, but some data suggest the slow current may play an important role.

Original languageEnglish
Pages (from-to)315-321
Number of pages7
JournalCirculation
Volume53
Issue number2
StatePublished - 1976

Fingerprint

Aprindine
Ouabain
Dogs
Verapamil
Canrenoic Acid
Procainamide
Calcium Chloride
Quinidine
Phenytoin
Lidocaine
Propranolol
Potassium
Control Groups
Serum

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Foster, P. R., King, R. M., DeB Nicoll, A., & Zipes, D. P. (1976). Suppression of ouabain induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents. Circulation, 53(2), 315-321.

Suppression of ouabain induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents. / Foster, P. R.; King, R. M.; DeB Nicoll, A.; Zipes, D. P.

In: Circulation, Vol. 53, No. 2, 1976, p. 315-321.

Research output: Contribution to journalArticle

Foster, PR, King, RM, DeB Nicoll, A & Zipes, DP 1976, 'Suppression of ouabain induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents', Circulation, vol. 53, no. 2, pp. 315-321.
Foster, P. R. ; King, R. M. ; DeB Nicoll, A. ; Zipes, D. P. / Suppression of ouabain induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents. In: Circulation. 1976 ; Vol. 53, No. 2. pp. 315-321.
@article{d82cf2444a1e4226b685363eddc8d116,
title = "Suppression of ouabain induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents",
abstract = "Three groups of dogs were given ouabain (mean 60 μg/kg) until an accelerated ventricular escape (AVE) and repetitive ventricular response (RVR) followed cessation of pacing. In a group of six control dogs, the AVE and RVR were found to occur at stable escape intervals for periods of at least three hours. A second group of dogs received various antiarrhythmic agents in an attempt to suppress the AVE and RVR. Quinidine, diphenylhydantoin, lidocaine, procainamide, and propranolol, were successful in only 0 to 33{\%} of trials. Potassium canrenoate, 12 mg/kg was unsuccessful in three dogs. Verapamil, by bolus, suppressed RVR in 41{\%} and AVE in 21{\%} of trials. KCl, infused until AVE and RVR were suppressed, was successful when the mean serum potassium rose from 3.8 mEq/L to 7.2 mEq/L. Aprindine, 2.86 mg/kg, suppressed AVE and RVR in 14 of 14 dogs. In the third group of dogs, verapamil was infused continuously and suppressed RVR and AVE at a mean cumulative dose of 2.93 mg/kg. Calcium chloride reversed aprindine and verapamil induced suppression of RVR and AVE. This study demonstrates that RVR and AVE resist suppression by available antiarrhythmic agents in clinically used doses. Only aprindine was 100{\%} successful at doses used in man. The ionic pathogenesis of RVR and AVE is unknown, but some data suggest the slow current may play an important role.",
author = "Foster, {P. R.} and King, {R. M.} and {DeB Nicoll}, A. and Zipes, {D. P.}",
year = "1976",
language = "English",
volume = "53",
pages = "315--321",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Suppression of ouabain induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents

AU - Foster, P. R.

AU - King, R. M.

AU - DeB Nicoll, A.

AU - Zipes, D. P.

PY - 1976

Y1 - 1976

N2 - Three groups of dogs were given ouabain (mean 60 μg/kg) until an accelerated ventricular escape (AVE) and repetitive ventricular response (RVR) followed cessation of pacing. In a group of six control dogs, the AVE and RVR were found to occur at stable escape intervals for periods of at least three hours. A second group of dogs received various antiarrhythmic agents in an attempt to suppress the AVE and RVR. Quinidine, diphenylhydantoin, lidocaine, procainamide, and propranolol, were successful in only 0 to 33% of trials. Potassium canrenoate, 12 mg/kg was unsuccessful in three dogs. Verapamil, by bolus, suppressed RVR in 41% and AVE in 21% of trials. KCl, infused until AVE and RVR were suppressed, was successful when the mean serum potassium rose from 3.8 mEq/L to 7.2 mEq/L. Aprindine, 2.86 mg/kg, suppressed AVE and RVR in 14 of 14 dogs. In the third group of dogs, verapamil was infused continuously and suppressed RVR and AVE at a mean cumulative dose of 2.93 mg/kg. Calcium chloride reversed aprindine and verapamil induced suppression of RVR and AVE. This study demonstrates that RVR and AVE resist suppression by available antiarrhythmic agents in clinically used doses. Only aprindine was 100% successful at doses used in man. The ionic pathogenesis of RVR and AVE is unknown, but some data suggest the slow current may play an important role.

AB - Three groups of dogs were given ouabain (mean 60 μg/kg) until an accelerated ventricular escape (AVE) and repetitive ventricular response (RVR) followed cessation of pacing. In a group of six control dogs, the AVE and RVR were found to occur at stable escape intervals for periods of at least three hours. A second group of dogs received various antiarrhythmic agents in an attempt to suppress the AVE and RVR. Quinidine, diphenylhydantoin, lidocaine, procainamide, and propranolol, were successful in only 0 to 33% of trials. Potassium canrenoate, 12 mg/kg was unsuccessful in three dogs. Verapamil, by bolus, suppressed RVR in 41% and AVE in 21% of trials. KCl, infused until AVE and RVR were suppressed, was successful when the mean serum potassium rose from 3.8 mEq/L to 7.2 mEq/L. Aprindine, 2.86 mg/kg, suppressed AVE and RVR in 14 of 14 dogs. In the third group of dogs, verapamil was infused continuously and suppressed RVR and AVE at a mean cumulative dose of 2.93 mg/kg. Calcium chloride reversed aprindine and verapamil induced suppression of RVR and AVE. This study demonstrates that RVR and AVE resist suppression by available antiarrhythmic agents in clinically used doses. Only aprindine was 100% successful at doses used in man. The ionic pathogenesis of RVR and AVE is unknown, but some data suggest the slow current may play an important role.

UR - http://www.scopus.com/inward/record.url?scp=0017279902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017279902&partnerID=8YFLogxK

M3 - Article

C2 - 1245038

AN - SCOPUS:0017279902

VL - 53

SP - 315

EP - 321

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2

ER -